Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study-Reference-Cited by-同舟云学术

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

Published:1999-12 Issue:9195 Volume:354 Page:2036-2040
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rosing Jan,Middeldorp Saskia,Curvers Joyce,Thomassen M Christella L GDlig;,Nicolaes Gerry AF,Meijers Joost CM,Bouma Bonno N,Büller Harry R,Prins Martin H,Tans Guido

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Oral contraceptives and cardiovascular disease;Stadel;N Engl J Med,1981

2. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease;Lancet,1995

3. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components;Jick;Lancet,1995

4. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing third-generation progestagen;Bloemenkamp;Lancet,1995

5. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study;Spitzer;BMJ,1996

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saponins from Allium macrostemon Bulbs Attenuate Endothelial Inflammation and Acute Lung Injury via the NF-κB/VCAM-1 Pathway;Molecules;2024-03-11

2. Incidence rate of venous thrombosis in women switching combined oral contraceptives: a cohort study;Research and Practice in Thrombosis and Haemostasis;2024-03

3. Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives;Blood;2024-01-04

4. State of the Art Management of Acute Pulmonary Embolism;JAP Academy Journal;2023-10-12

5. Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays;Research and Practice in Thrombosis and Haemostasis;2023-08